The Senlan Bay Forum - ISPE Biopharmaceutical Engineering Summit 2022 Has Come to a Successful Conclusion!
On December 9-10, 2022, the two-day Senlan Bay Forum – ISPE Biopharmaceutical Engineering Summit 2022 was successfully held in Shanghai Peony Garden! The summit focused on the segmental production of macromolecules; the difficulties in the industrialization of gene and cell therapy; the construction of compliant and efficient CGT facilities; the process performance qualification (PPQ) for biologic drugs submitted by China and the United States enterprises; listing application (BLA) and commercial production and operation management; trend analysis, learning and opportunities of audit findings in 2021-2022; the challenges and strategies of CMC development, production and quality control of ADC drugs; cost considerations of antibody drugs; feasibility suggestions for segmented production of biological products in my country; and many other topics.
This summit ISPE joined with two co-organizers, four sponsors, 39 industry experts, and nearly 1,000 participants in this wonderful academic information sharing. Let’s review the exciting content of the conference together!
Opening Speeches
Excellent Speeches by Online and Offline Speakers
Questions & Answers
Enthusiastic Communication
Take Notes Carefully
Tour of Senlan Bay
Senland Bay Forum - ISPE Biopharmaceutical Engineering Summit 2022 was led by Dr. Jimmy Li, chairman of the ISPE China Biopharmaceutical Engineering Subcommittee and CEO of WuXi Alliance. Many industry elite experts attended the conference and served as speakers (please See Agenda). Here, I would like to express my heartfelt thanks to Dr. Li, the summit chairman, Dr. Zhu Huilin, the conference host, and all the speakers and experts!
At the same time, special thanks to the following four sponsors for their contributions to the smooth holding of this summit! They are: Thermo Fisher Scientific (China) Co., Ltd.; Glaser Life Sciences (Shanghai) Co., Ltd. CYTIVA, Tofflon Technology Group Co., Ltd.; Truking Technology Co., Ltd., Wuxi Biologics, Shanghai Sen Lan WaiGaoqiao Commercial Operation Center Co., Ltd. Hope to continue to join hands in the future and work together for the academic development of China's biopharmaceutical engineering!
Group Award
